Among the inflammatory proteins analyzed, Fibroblast Growth Factor 19 (FGF19), Urokinase‐Type Plasminogen Activator (uPA), Fibroblast Growth Factor 23 (FGF23), C‐C Motif Chemokine 28 (CCL28), and Interleukin‐18 Receptor 1 (IL18R1) exhibited protective effects against cervical cancer, as evidenced by odds ratios (ORs) less than 1 (Figure 2A). This evidence concerns the gene FGF23 and cervical cancer.